COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 828: Articles 8271-8280  | Next

Biopsychosocial response to the COVID-19 lockdown in people with major depressive disorder and multiple sclerosis.
Siddi, S., Gine Vazquez, I., Bailon, R., Matcham, F., Lamers, F., Kontaxis, S., Laporta Puyal, E., Garcia, E., Arranz, B., Dallacosta, G., Guerrero Perez, A. I., Zabalza, A., Buron, M., Comi, G., Leocani, L., Annas, P., Hotopf, M., Penninx, B., Magyari, M., Sorensen, P., Montalban, X., Lavalle, G., Ivan, A., Oetzmann, C., White, K., Difrancesco, S., Locatelli, P., Aguilo, J., Narayan, V., Folarin, A., Dobson, R., Dineley, J. A., Leightley, D., Cummins, N., Ranjan, Y., Rashid, Z., Rintala, A., De Girolamo, G., Preti, A., Simblett, S., Wykes, T., Myin-Germeys, I., Haro, J. M.
10.1101/2022.05.10.22274890 — Posted: 2022-05-10
High but Short-lived anti-SARS-CoV2 neutralizing, IgM, IgA, and IgG levels among mRNA-vaccinees compared to naturally-infected participants
Abou Saleh, H., Abo Halawa, B., Younes, S., Younes, N., Al-Sadeq, D., Shurrab, F., Liu, N., Qotba, H., AlDewik, N., Ismail, A., YASSINE, H. M., Abu-Raddad, L. J., Nasrallah, G.
10.1101/2022.05.08.22274817 — Posted: 2022-05-10
PixelPrint: Three-dimensional printing of realistic patient-specific lung phantoms for validation of computed tomography post-processing and inference algorithms
Shapira, N., Donovan, K., Mei, K., Geagan, M., Roshkovan, L., Gang, G., Abed, M., Linna, N. B., Cranston, C. P., Leary, C. N., Dhanaliwala, A. H., Kontos, D., Litt, H. I., Stayman, J. W., Shinohara, R. T., Noël, P. B.
10.1101/2022.05.06.22274739 — Posted: 2022-05-10
Clinical characteristics of COVID-19 patients admitted to Intensive Care Unit in Panama during the first pandemic wave admissions in 2020.
Vega, S., Gomez Blizniak, A., Theoktisto Ballanis, S., Cisneros, G., Villalobos, D., Armuelles, A. K., Moreno, L., Fusumada, F., Gonzalez, J., Romero, E., Torres-Atencio, I., Cubilla-Batista, I., Goodridge, A.
10.1101/2022.05.08.22274803 — Posted: 2022-05-10
mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia
Li, R., Liu, H., Fairley, C. K., Ong, J. J., Guo, Y., Zou, Z., Xie, L., Zhuang, G., Li, Y., Shen, M., Zhang, L.
10.1101/2022.05.08.22274797 — Posted: 2022-05-10
10.4 Million Children Affected by COVID-19-associated Orphanhood and Caregiver Death: An Imperative for Action
Hillis, S., Ntwali N'konzi, J.-P., Msemburi, W., Cluver, L., Villaveces, A., Flaxman, S., Unwin, H. J. T.
10.1101/2022.05.08.22274788 — Posted: 2022-05-10
Phase I study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
Martin Orozco, N., Vale, N., Mihic, A., Amor, T., Reiter, L., Arita, Y., Samson, R., Hu, Q., Gingras, A.-C., Sorenson, B., Marcusson, E., Patel, P.
10.1101/2022.05.06.22274690 — Posted: 2022-05-10
Association between environmental levels of PM2.5 and mortality from SARS-CoV-2 in inhabitants of Mexico City
Moreno-Santillan, A. A., Rivas-Ruiz, R., Fuentes-Valdivieso, R., Roy-Garcia, I. A.
10.1101/2022.05.08.22274818 — Posted: 2022-05-10
Decision trees for COVID-19 prognosis learned from patient data: Desaturating the ER with Artificial Intelligence
Bernaola, N., De Lima, G., Riano, M., Llanos, L., Heili-Frades, S., Sanchez, O., Lara, A., Plaza, G., Carballo, C., Gallego, P., Larranaga, P., Bielza, C.
10.1101/2022.05.09.22274832 — Posted: 2022-05-10
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Park, Y.-J., Pinto, D., Walls, A. C., Liu, Z., De Marco, A., Benigni, F., Zatta, F., Silacci-Fregni, C., Bassi, J., Sprouse, K. R., Addetia, A., Bowen, J. E., Stewart, C., Giurdanella, M., Saliba, C., Guarino, B., Schmid, M., Franko, N., Logue, J., Dang, H. V., di Iulio, J., Rivera, W., Schnell, G., Lempp, F., Janer, J., Abdelnabi, R., Maes, P., Ferrari, P., Ceschi, A., Giannini, O., de Melo, G., Kergoat, L., Bourhy, H., Neyts, J., Soriagha, L., Purcell, L., Snell, G., Whelan, S., Lanzavecchia, A., Virgin, H., Piccoli, L., Chu, H., Pizzuto, M. S., Corti, D., Veesler, D.
10.1101/2022.05.08.491108 — Posted: 2022-05-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).